-+ 0.00%
-+ 0.00%
-+ 0.00%

Neuphoria says it is in talks with Scancell on potential acquisition

PUBT·06/26/2026 20:15:20
Listen to the news
Neuphoria says it is in talks with Scancell on potential acquisition
  • Scancell is in talks to acquire Neuphoria Therapeutics in a potential combination.
  • The deal would leave Scancell as a Nasdaq-listed company once the transaction closes.
  • No agreement is certain, with terms still under discussion and the transaction not assured.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuphoria Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606261615PRIMZONEFULLFEED9753372) on June 26, 2026, and is solely responsible for the information contained therein.